Related Experiment Video

Updated: May 29, 2026

A Nonsequencing Approach for the Rapid Detection of RNA Editing
08:50

A Nonsequencing Approach for the Rapid Detection of RNA Editing

Published on: April 21, 2022

A-to-I RNA editing: the "ADAR" side of human cancer

Federica Galeano1, Sara Tomaselli, Franco Locatelli

  • 1RNA Editing Laboratory, Oncohaematology Department, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.

Seminars in Cell & Developmental Biology
|September 21, 2011
PubMed

Insights

RNA editing, specifically A-to-I RNA editing catalyzed by ADAR enzymes, is emerging as a key factor in cancer development. Understanding ADARs

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Carcinogenesis is a complex process influenced by genetic and environmental factors.
  • DNA mutations have historically been key in understanding cancer pathways.
  • RNA editing, a post-transcriptional modification, is increasingly recognized in human diseases, including cancer.

Purpose of the Study:

  • To review the current understanding of A-to-I RNA editing in the context of cancer.
  • To explore the role of ADAR enzymes in carcinogenesis.
  • To provide a novel perspective on RNA editing in cancer development.

Main Methods:

  • Literature review of studies on A-to-I RNA editing and cancer.
  • Analysis of the role of Adenosine Deaminases Acting on RNA (ADAR) enzymes.
  • Synthesis of existing knowledge to form new insights.

Main Results:

  • A-to-I RNA editing introduces specific nucleotide changes (A-to-I/G) in RNA sequences.
  • ADAR enzymes are crucial for catalyzing A-to-I RNA editing.
  • The expression and activity of ADARs are tightly regulated in normal cells.

Conclusions:

  • A-to-I RNA editing represents a significant layer of gene regulation in cancer.
  • Dysregulation of ADAR enzymes may contribute to the multi-stage process of carcinogenesis.
  • Further research into RNA editing mechanisms can offer new therapeutic targets for cancer.

More Related Videos

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer09:38

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Published on: March 28, 2018

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay10:57

Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

Published on: August 14, 2018

Related Concept Videos

RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...